Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-056237

VP, Clinical Trial Operations sold 18,135 shares at an average $11.60 ($210,431)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-17 Sale : show line 1 in the form −3,541 $13.04 $46,170 102,594 D
2023-11-20 Sale : show line 2 in the form −14,594 $11.26 $164,261 88,000 D
Open-market sales · 18,135 sh · avg $11.60 · $210,431
Loading xslF345X05/doc4.xml…